Head-to-head
Noom Med vs HealthRX
Compared on semaglutide across the eight dimensions this database records. They differ on 5 of those eight. HealthRX is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Noom Med is $199 a month all-in for semaglutide; HealthRX is $133. Over twelve months that is $2,388 against $1,188. Value Scores are 73.1 and 93.4 out of 100.
Semaglutide
Plan pages: Noom Med plans · HealthRX plans
At 2.4 mg/week, Noom Med is $199 a month all-in and HealthRX is $133 — $66 apart, or $792 across a year. Over twelve months the totals are $2,388 (billed monthly) and $1,188 (prepaid term).
Noom Med charges a flat $199 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
HealthRX charges a flat $133 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | Noom Med | Rank | HealthRX | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $199 | 17/32 | $133 | 3/32 | HealthRX by $66 |
| 0.5 mg | $199 | 12/21 | $133 | 2/21 | HealthRX by $66 |
| 1 mg | $199 | 12/21 | $133 | 2/21 | HealthRX by $66 |
| 1.7 mg | $199 | 12/21 | $133 | 2/21 | HealthRX by $66 |
| 2.4 mg | $199 | 14/29 | $133 | 2/29 | HealthRX by $66 |
HealthRX is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, Noom Med sits 10 of 29 on all-in monthly cost and HealthRX sits 3. There are 6 other programs priced between them. The field median is $249 and the floor is $129, so both sit below the median. Noom Med is $70 above the cheapest semaglutide program on record. HealthRX is $4 above the cheapest semaglutide program on record.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — Noom Med undercuts it by $150, HealthRX by $216. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Noom Med | HealthRX | Cheaper |
|---|---|---|---|
| Month to month | $199 | — | only Noom Med publishes this term |
| 3-month term | — | $133 | only HealthRX publishes this term |
| 12-month term | — | $99 | only HealthRX publishes this term |
| Settled dose | Noom Med | HealthRX | Difference |
|---|---|---|---|
| 0.25 mg | $2,388 | $1,596 | $792 apart |
| 0.5 mg | $2,388 | $1,596 | $792 apart |
| 1 mg | $2,388 | $1,596 | $792 apart |
| 1.7 mg | $2,388 | $1,596 | $792 apart |
| 2.4 mg | $2,388 | $1,596 | $792 apart |
Noom Med publishes no rate for 3-month term, 6-month term, 12-month term; HealthRX publishes none for month to month, 6-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $2,388 on Noom Med and $1,596 on HealthRX. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.
Value Scores are 73.1 for Noom Med and 93.4 for HealthRX, against a semaglutide category floor of $129. HealthRX leads by 20.3 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Noom Med | 45.4 | 12.8 | 10 | 5 | 73.1 |
| HealthRX | 67.9 | 10.5 | 10 | 5 | 93.4 |
Where the two programs differ
All-in monthly
HealthRX is cheaper month to month — $133 against $199, a gap of $66 every month, or $792 across a year if both rates hold.
Cancellation terms
Cancellation differs: Noom Med states Per plan terms, while HealthRX states Per provider terms; confirm at enrollment. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Noom Med asks for Program-based; HealthRX asks for 12-month or 3-month plans only; no month-to-month rate published. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Evidence status
The two prices are not equally well evidenced. Noom Med's figure is provider-stated and HealthRX's is reported. Noom Med rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $2,388 for Noom Med and $1,188 for HealthRX. HealthRX is lower by $1,200 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Dose policy
Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Noom Med Official site
Noom bundles its behavior program with medication access; compounded semaglutide lists at $199/month all-in.
It names its compounding pharmacy — Partner pharmacies, recorded as Partner network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Program-based; cancellation is Per plan terms; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — noom.com program page capture 2026-08-08
Watch: Noom's program bundling changes frequently; confirm what the quoted figure includes.
HealthRX Official site
HealthRX offers flat per-dose compounded GLP-1 pricing on 12-month and 3-month commitment plans. Its $99/mo semaglutide and $179/mo tirzepatide on the twelve-month plan rank among the lowest annualized figures in the market. No month-to-month rate is published.
It does not publicly name its compounding pharmacy; the record shows healthrx.com (pharmacy partner not publicly named), so who actually makes the medication cannot be independently verified; commitment terms are 12-month or 3-month plans only; no month-to-month rate published; cancellation is Per provider terms; confirm at enrollment; availability is stated as Confirm availability at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, capture verified 2026-07-18 on healthrx.com
Watch: HealthRX publishes no month-to-month rate; the $99/mo sema and $179/mo tirz are 12-month plan rates. The lowest commitment available is the 3-month plan ($133 sema, $209 tirz). Reported status — RangeYourself verified 2026-07-18 on healthrx.com; our independent checkout is pending.
Which molecules each one carries
Noom Med carries semaglutide at $199 a month; does not offer tirzepatide.
HealthRX carries tirzepatide at $209 a month and semaglutide at $133 a month.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Noom Med does not publish
- no published twelve-month semaglutide rate
- no state-by-state availability list — it says Most US states
- no specific cancellation or refund terms
HealthRX does not publish
- no named compounding pharmacy
- no state-by-state availability list — it says Confirm availability at intake
- no specific cancellation or refund terms
Ask Noom Med and HealthRX for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. HealthRX carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. HealthRX publishes a twelve-month rate of $99 a month against $133 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, HealthRX Official site wins this matchup. And if you would rather trust a better-evidenced number, noom med's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Noom Med's semaglutide price is provider-stated as of 2026-08-08; HealthRX's is reported as of 2026-07-18.
Questions
Is Noom Med or HealthRX cheaper for semaglutide?
HealthRX is cheaper on all-in monthly cost at 2.4 mg/week: $133 against $199, a difference of $66 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Noom Med versus HealthRX?
Noom Med works out to $2,388 across twelve months and HealthRX to $1,188, on the plan terms each publishes.
Does Noom Med or HealthRX raise the price as the dose goes up?
Noom Med: no, it charges one flat rate at every dose. HealthRX: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Noom Med and HealthRX differ?
5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Noom Med and HealthRX names its pharmacy?
Noom Med does — Partner pharmacies. HealthRX does not, recording only healthrx.com (pharmacy partner not publicly named), so who makes its medication cannot be independently verified.
How well evidenced are the Noom Med and HealthRX prices?
Noom Med's semaglutide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-08. HealthRX's is reported, captured 2026-07-18. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Noom Med official site · HealthRX official site. Compounded tirzepatide and semaglutide are not FDA-approved products.